Independent
Tenure on this board
2.5 yrs
Meeting calendar
ACN · Annual meeting · Wednesday, January 28, 2026
Accenture PLC
10 nominees · 7 ballot items.
Appointment of ten directors (Proposal 1); non-binding vote on executive compensation (Proposal 2); approval of Amended SIP (Proposal 3); non-binding ratification of auditor and binding authorization of board remuneration (Proposal 4); Irish law proposals: board authority to issue shares (Proposal 5); board authority to opt-out of pre-emption rights (Proposal 6); determine the price range for re-allotment of treasury shares (Proposal 7).
Market cap
$95.9B
1Y TSR
-51.2%
Board grade
C-
Record date
Dec 1, 2025
Filing
DEF 14A
Meeting concluded · Jan 28, 2026
Follow how the vote landed and what changed on Accenture PLC’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
Proposals
On the ballot7
- 1
Appointment of Directors
ManagementBoard: FORElection of ten director nominees to Accenture plc’s Board at the annual meeting.
- 2
Non-Binding Vote to Approve Executive Compensation
ManagementBoard: FORAdvisory vote approving the compensation of the company’s named executive officers as disclosed in the proxy statement.
- 3
Approval of Amended and Restated Accenture plc 2010 Share Incentive Plan
ManagementBoard: FORApprove amendments to the Accenture SIP to add shares, extend its term and adjust administration.
- 4
Non-Binding Ratification of Appointment of Independent Auditor and Binding Authorization of the Board to Determine Its Remuneration
ManagementBoard: FORRatify KPMG LLP as independent auditor and authorize the Board to determine its remuneration (and for the Audit Committee to pre-approve non-audit services).
- 5
Board Authority to Issue Shares
ManagementBoard: FORRenewal of authority under Irish law to issue up to 20% of issued ordinary share capital for 18 months.
- 6
Board Authority to Opt-Out of Pre-Emption Rights
ManagementBoard: FORRenewal of authority to opt-out of pro-rata subscription rights in certain share issuances.
- 7
Determine Price Range for Re-Allotment of Treasury Shares
ManagementBoard: FORRenewal of the price range (minimum 95% of closing price; maximum 120%) for re-allotment of treasury shares, valid for 18 months.
Director elections
Nominees on the ballot10
Independent
Tenure on this board
3.3 yrs
Independent
Tenure on this board
10.5 yrs
Also a director at
Abbott Laboratories (ABT)Mondelez International Inc (MDLZ)
Independent
Tenure on this board
1.6 yrs
Independent
Tenure on this board
12.5 yrs
Also a director at
Bristol Myers Squibb Co (BMY)Warner Bros Discovery Inc (WBD)Mondelez International Inc (MDLZ)
Independent
Tenure on this board
8.3 yrs
Also a director at
First Solar Inc (FSLR)
Independent
Tenure on this board
11.5 yrs
Also a director at
Schwab Charles Corp (SCHW)
Independent
Tenure on this board
9.0 yrs
Also a director at
Hyatt Hotels Corp (H)
Independent
Tenure on this board
1.4 yrs
Not independent
Tenure on this board
6.9 yrs
Ownership
Latest 13F quarterTop institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | Swedbank AB | 0.2% | 1,124,180 | $140M |
| 2 | WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST | 0.2% | 1,100,000 | $137M |
| 3 | DAVENPORT Co LLC | 0.1% | 823,014 | $102M |
| 4 | Value Partners Investments Inc. | 0.1% | 405,346 | $50M |
| 5 | CONFLUENCE INVESTMENT MANAGEMENT LLC | 0.1% | 340,644 | $42M |
| 6 | WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 0.0% | 292,646 | $30M |
| 7 | PARK NATIONAL CORP /OH/ | 0.0% | 220,048 | $27M |
| 8 | Y-Intercept (Hong Kong) Ltd | 0.0% | 205,916 | $26M |
| 9 | Czech National Bank | 0.0% | 174,751 | $22M |
| 10 | Seilern Investment Management Ltd | 0.0% | 163,642 | $20M |
Peers
Nearest market capOther Technology sector meetings6
Upcoming shareholder meetings at Accenture PLC’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Flex LtdFLEX
Annual meeting·Aug 5, 2026·$44.4B
Microchip Technology IncMCHP
Annual meeting·Aug 18, 2026·$44.3B
Samsara IncIOT
Annual meeting·Jul 22, 2026·$21.8B
Nextpower IncNXT
Annual meeting·Aug 18, 2026·$16.1B
Dynatrace IncDT
Annual meeting·Aug 26, 2026·$13.1B
Allegro Microsystems IncALGM
Annual meeting·Aug 5, 2026·$8.8B
Reference
Frequently asked questions
- When is the Accenture PLC 2026 annual meeting?
- Accenture PLC (ACN) holds its 2026 annual shareholder meeting on Wednesday, January 28, 2026.
- What is the record date for the Accenture PLC 2026 meeting?
- The record date for the Accenture PLC 2026 meeting is Monday, December 1, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Accenture PLC's 2026 meeting?
- The board is presenting 10 director nominees at the Accenture PLC 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Accenture PLC 2026 meeting?
- Shareholders will vote on 7 proposals at the Accenture PLC 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.